Journal
JOURNAL OF IMMUNOLOGY
Volume 200, Issue 8, Pages 2581-2591Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1701622
Keywords
-
Categories
Funding
- Instituto de Salud Carlos III (Ministerio de Economia y Competitividad, Cofinanciado por Fondo Europeo de Desarrollo Regional, Union Europea, Una Manera de Hacer Europa) [RD12/0036/0046, PI16/00423]
- Generalitat de Catalunya grant [2014SGR-552]
- CERCA Programme/Generalitat de Catalunya
- Josep Carreras Leukaemia Research Institute grant [CEL029]
- Institut d'Investigacions Biomediques August Pi i Sunyer starting grant [II040060]
Ask authors/readers for more resources
Mechanisms of immune regulation may control proliferation of aberrant plasma cells (PCs) in patients with monoclonal gammopathy of undetermined significance (MGUS) preventing progression to active multiple myeloma (MM). We hypothesized that CD85j (LILRB1), an inhibitory immune checkpoint for B cell function, may play a role in MM pathogenesis. In this study, we report that patients with active MM had significantly lower levels of CD85j and its ligand S100A9. Decreased CD85j expression could also be detected in the premalignant condition MGUS, suggesting that loss of CD85j may be an early event promoting tumor immune escape. To gain insight into the molecular mechanisms underlying CD85j functions, we next enforced expression of CD85j in human myeloma cell lines by lentiviral transduction. Interestingly, gene expression profiling of CD85j-overexpressing cells revealed a set of downregulated genes with crucial functions in MM pathogenesis. Furthermore, in vitro functional assays demonstrated that CD85j overexpression increased susceptibility to T cell- and NK-mediated killing. Consistently, ligation of CD85j decreased the number of PCs from individuals with MGUS but not from patients with MM. In conclusion, downregulation of inhibitory immune checkpoints on malignant PCs may provide a novel mechanism of immune escape associated with myeloma pathogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available